Amplicor

Updated October 6, 2026

Overview

Product sourcing insights & recommendations

U.S. Food and Drug Administration (.gov)

National Institutes of Health (NIH) | (.gov)

National AIDS Treatment Advocacy Project - NATAP

52 来源

The term Amplicor primarily refers to a foundational line of automated molecular diagnostic products developed by Roche Molecular Systems. Introduced in the 1990s, it revolutionized the field by automating the Polymerase Chain Reaction (PCR) process for clinical labs Nih Questpair.

Product Insights

The Amplicor product line, specifically the COBAS AMPLICOR system, was designed to detect and quantify DNA and RNA for various infectious diseases.

Core Technology: It uses nucleic acid amplification to detect viral and bacterial targets like HIV-1, Hepatitis C (HCV), and sexually transmitted infections like Chlamydia and Gonorrhea Health Fda.
Automation: The system integrated thermal cycling, incubation, and photometer detection into a single platform, significantly reducing manual labor and the risk of cross-contamination compared to early manual PCR Oup Semanticscholar.
Product Status: While Amplicor was a market leader for decades, Roche has transitioned its portfolio to next-generation platforms like the cobas 4800, 6800, and 8800 systems, which offer higher throughput and integrated AI-driven data analysis Prnewswire Roche.

Market Trends (2025–2026)

The market for molecular diagnostics, where Amplicor once led, is currently defined by several key shifts:

Projected Growth: The global PCR market is expected to grow from $26.9 billion in 2026 to over $31 billion by 2033, driven by genetic testing and oncology Persistencemarketresearch Mordorintelligence.
Decentralization: There is a strong trend toward Point-of-Care (PoC) and decentralized testing, moving away from the large, centralized lab model that Amplicor originally served Persistencemarketresearch Linkedin.
Technological Shift: Real-time PCR (qPCR) and Digital PCR (dPCR) have largely replaced end-point PCR systems like the original Amplicor due to their superior sensitivity and faster turnaround times Fortunebusinessinsights Precedenceresearch.
Localization: In late 2025, Roche began launching quantitative PCR systems specifically tailored for local markets (e.g., China), indicating a trend toward regional customization of diagnostic hardware Roche.

B2B Sourcing Context

Current B2B availability shows a clear focus on modern alternatives. While legacy Amplicor machines are rare in new listings, high-throughput systems from competing brands (e.g., Biobase) and newer Roche models dominate the wholesale market.

The Amplicor line has largely transitioned to newer platforms. Would you like to:

Sources & References

52 sources cited · Verified industry data & reports

Roche Amplicor HIV-1 Monitor Test

U.S. Food and Drug Administration (.gov)

Roche Amplicor HIV-1 Monitor Test … an in vitro nucleic acid amplification test for the quantitation of Human Immunodeficiency Virus Type 1 ( ...

COBAS AMPLICOR: fully automated RNA and DNA ...

National Institutes of Health (NIH) | (.gov)

The COBAS AMPLICOR system automates amplification and detection of target nucleic acids, making diagnostic PCR routine for a variety of infectious diseases.

Roche Receives FDA Clearance for Cobas New More ...

National AIDS Treatment Advocacy Project - NATAP

The Cobas Amplicor HIV-1 Monitor Test (version 1.5) is an automated assay that amplifies and detects genetic material, allowing for accurate quantification

COBAS AMPLICOR: fully automated RNA and DNA ...

Oxford Academic

The COBAS AMPLICOR system automates amplification and detection of target nucleic acids, making diagnostic PCR routine for a variety of infectious diseases. The ...

Roche Amplicor

QuestPair

Roche's AMPLICOR PCR System is a fully automated platform designed for the amplification and detection of DNA and RNA, streamlining the polymerase chain ...

Analysis and genotyping of PCR products of the Amplicor ...